NCT00444028 - Staccato Loxapine Single Dose PK | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions

Schizophrenia

Interventions

DRUG

inhaled Loxapine 0.625 mg

Single 0.625 mg (lowest) dose of inhaled loxapine

DRUG

inhaled Loxapine 1.25 mg

Single 1.25 mg (2nd) dose of inhaled loxapine

DRUG

inhaled Loxapine 2.5 mg

Single 2.5 mg (3rd) dose of inhaled loxapine

DRUG

inhaled Loxapine 5 mg

Single 5 mg (4th) dose of inhaled loxapine

DRUG

inhaled Loxapine 10 mg

Single 10 mg (5th) dose of inhaled loxapine

DRUG

inhaled Placebo (0 mg)

Single placebo dose of inhaled loxapine

Trial Locations (1)

Covance Clinical Research Unit Inc., d/b/a Covance GFI Research, Evansville